08.12.2018
The Resaphene has received the patent grant notice from the US Patent Authority. Now the only tinnitus therapy with proof of efficacy on the market in the two target regions Europe and the US is protected.
Back08.12.2018
The Resaphene has received the patent grant notice from the US Patent Authority. Now the only tinnitus therapy with proof of efficacy on the market in the two target regions Europe and the US is protected.
BackTestimonials